BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 12486618)

  • 1. [N-acetylcystein in the therapy of chronic bronchitis].
    Reichenberger F; Tamm M
    Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
    Brocard H; Charpin J; Germouty J
    Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral N-acetylcysteine on mucus clearance.
    Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
    Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucolytic and antibiotic effect of a new compound in chronic bronchitis.
    Bŭrgi H
    Chemotherapy; 1975; 21(3-4):167-74. PubMed ID: 1098866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Con: antibiotic use in exacerbations of chronic bronchitis.
    Nicotra MB; Kronenberg RS
    Semin Respir Infect; 1993 Dec; 8(4):254-8. PubMed ID: 7938922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute and chronic bronchitis].
    Speich R
    Ther Umsch; 1992 Apr; 49(4):227-33. PubMed ID: 1615456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Papi A; Alfano F; Bigoni T; Mancini L; Mawass A; Baraldi F; Aljama C; Contoli M; Miravitlles M
    Arch Bronconeumol; 2024 May; 60(5):269-278. PubMed ID: 38555190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
    Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
    Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
    Boman G; Bäcker U; Larsson S; Melander B; Wåhlander L
    Eur J Respir Dis; 1983 Aug; 64(6):405-15. PubMed ID: 6350033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review.
    Stey C; Steurer J; Bachmann S; Medici TC; Tramèr MR
    Eur Respir J; 2000 Aug; 16(2):253-62. PubMed ID: 10968500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
    Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
    Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.
    Rasmussen JB; Glennow C
    Eur Respir J; 1988 Apr; 1(4):351-5. PubMed ID: 3294038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
    Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
    Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].
    Gillissen A
    Pneumologie; 2011 Sep; 65(9):549-57. PubMed ID: 21761386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mucolytic effects of acetylcysteine compared with bromhexine and a placebo in patients with chronic bronchitis].
    Heinig JH; Pedersen B; Andersen I; Dalgaard CE; Rasmussen O; Weeke ER; Enk B
    Ugeskr Laeger; 1985 Nov; 147(46):3694-7. PubMed ID: 3907080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.